Cure My Disease

Don't miss your cure!

 Log in / Sign up

Supercharged immune cells take on tough ovarian cancers

NCT ID NCT06483048

Recruiting now Disease control Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests a new treatment for people with ovarian cancer that has returned or is resistant to standard platinum chemotherapy. The treatment uses a patient's own immune cells (T cells), which are trained in a lab to recognize and attack a protein called MUC1 found on cancer cells. The main goals are to find the safest dose and see if the therapy can shrink tumors. About 12 participants will be enrolled at Mayo Clinic.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT FALLOPIAN TUBE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube carcinoma fallopian tube neoplasm ovarian cancer ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PLATINUM-RESISTANT FALLOPIAN TUBE CARCINOMA PLATINUM-RESISTANT OVARIAN CARCINOMA PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA RECURRENT FALLOPIAN TUBE CARCINOMA RECURRENT FALLOPIAN TUBE CARCINOSARCOMA RECURRENT FEMALE REPRODUCTIVE SYSTEM CARCINOMA RECURRENT OVARIAN CARCINOMA RECURRENT OVARIAN CARCINOSARCOMA RECURRENT PLATINUM-RESISTANT FALLOPIAN TUBE CARCINOMA RECURRENT PLATINUM-RESISTANT OVARIAN CARCINOMA RECURRENT PRIMARY PERITONEAL CARCINOMA RECURRENT PRIMARY PERITONEAL CARCINOSARCOMA REFRACTORY FALLOPIAN TUBE CARCINOMA REFRACTORY FEMALE REPRODUCTIVE SYSTEM CARCINOMA REFRACTORY OVARIAN CARCINOMA REFRACTORY PRIMARY PERITONEAL CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Arizona

    RECRUITING

    Scottsdale, Arizona, 85259, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••